Clinical trials: Pigment Disorders
Neonatal Hyperbilirubinemia
Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study)
Background: Neonatal hyperbilirubinemia is the most common reason for admission in the neonatal period (first month of life) worldwide and at SMRU.
- Trial name
- NCT02361788
- Where
- Thailand
- Volunteers
- 1,710 people, healthy volunteers welcome
- Sponsor
- University of Oxford
Age-Related Macular Degeneration
The Influence of Lutein Supplements on Age-related Macular Degeneration
Rationale: Age-related macular degeneration is the most common cause of blindness in the industrialized world. Macular pigment is hypothesized to protect against the vision loss in this disease. Objective: 1.
- Trial name
- NCT01042860
- Testing
- Lutein
- Where
- 2 sites in Netherlands, United Kingdom
- Volunteers
- 80 people
- Sponsor
- Maastricht University Medical Center
Aniridia, Eye Abnormality
Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens
This study will investigate congenital or developmental eye abnormalities that affect the iris, cornea and lens, and are usually accompanied by elevated pressure within the eye.
- Conditions
- Aniridia, Eye Abnormality, Ocular Hypertension, Open Angle Glaucoma
- Trial name
- NCT00001161
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- National Eye Institute (NEI)
Disaster, Vulnerable Populations
Nurses Taking On Readiness Measures - Mercer County, New Jersey
Nurses Taking On Readiness Measures (N-TORM) is an innovative nurse-driven household emergency preparedness (HEP) intervention modeled after an existing community intervention provided by emergency management personnel.
- Trial name
- NTORM (NCT05455580)
- Testing
- Nurses Taking On Readiness Measures (N-TORM)
- Where
- United States
- Volunteers
- 31 people, healthy volunteers welcome
- Sponsor
- Hunter College of City University of New York
Hyperpigmentation; Postinflammatory
Efficacy and Safety of Topical Cysteamine for Postinflammatory Hyperpigmentation
Post-inflammatory hyperpigmentation is a common pigmentary skin disorder that is refractory to treatment. The treatment for postinflammatory hyperpigmentation is limited.
- Trial name
- NCT05206318
- Testing
- Topical Cysteamine, Topical Vehicle Control
- Where
- Taiwan
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Chang Gung Memorial Hospital
Melasma
Green Banana Peel Extract for Melasma Treatment
To develop and evaluate a pharmaceutical formula based on green banana peel extract for the treatment of melasma.
- Trial name
- NCT05031689
- Testing
- SPF 30 sunscreen plus pharmaceutical formulation without green banana peel extract, SPF 30 sunscreen and pharmaceutical formulation containing green banana peel extract
- Where
- Brazil
- Volunteers
- 74 people
- Sponsor
- Universidade do Vale do Sapucai